JTT-751 for Treatment of Patients with Hyperphosphatemia on Peritoneal Dialysis

Publisher： Karger

E-ISSN： 1660-2110|128|1-2|135-140

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.128, Iss.1-2, 2014-11, pp. : 135-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Sexual Behaviors of Patients Receiving Peritoneal Dialysis Treatment

By Yılmaz Mualla

Sexuality and Disability, Vol. 29, Iss. 1, 2011-03 ,pp. : 21-32

Springer Publishing Company

Access to resources Recommend Favorite

Economic evaluation of sevelamer for the treatment of hyperphosphatemia in chronic kidney disease patients not on dialysis in the United Kingdom

By Thompson Melissa

Journal of Medical Economics, Vol. 16, Iss. 6, 2013-06 ,pp. : 744-755

Informa Healthcare

Access to resources Recommend Favorite

Opinions of Unmarried Patients Receiving Peritoneal Dialysis Treatment About Sexuality

By Yilmaz Mualla

Sexuality and Disability, Vol. 28, Iss. 4, 2010-12 ,pp. : 213-221

Springer Publishing Company

Access to resources Recommend Favorite

Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients

By Yilmaz F. M. Yilmaz G. Duranay M. Parpucu H. Şeneş M. Tekeli˙ N. Yücel D.

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 65, Iss. 8, 2005-12 ,pp. : 739-745

Informa Healthcare

Access to resources Recommend Favorite

Hyperleptinaemia, insulin resistance and survival in peritoneal dialysis patients

NEPHROLOGY, Vol. 20, Iss. 9, 2015-09 ,pp. : 617-624

John Wiley & Sons Inc

Access to resources Recommend Favorite